196 related articles for article (PubMed ID: 21243738)
1. Effects of mineralocorticoid receptor blockade on glucocorticoid-induced renal injury in adrenalectomized rats.
Rafiq K; Nakano D; Ihara G; Hitomi H; Fujisawa Y; Ohashi N; Kobori H; Nagai Y; Kiyomoto H; Kohno M; Nishiyama A
J Hypertens; 2011 Feb; 29(2):290-8. PubMed ID: 21243738
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological profile of CS-3150, a novel, highly potent and selective non-steroidal mineralocorticoid receptor antagonist.
Arai K; Homma T; Morikawa Y; Ubukata N; Tsuruoka H; Aoki K; Ishikawa H; Mizuno M; Sada T
Eur J Pharmacol; 2015 Aug; 761():226-34. PubMed ID: 26073023
[TBL] [Abstract][Full Text] [Related]
3. Prenatal overexposure to glucocorticoids programs renal 11β-hydroxysteroid dehydrogenase type 2 expression and salt-sensitive hypertension in the rat.
Tang JI; Kenyon CJ; Seckl JR; Nyirenda MJ
J Hypertens; 2011 Feb; 29(2):282-9. PubMed ID: 21045727
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of local aldosterone by eplerenone reduces renal structural damage in a novel model of chronic cyclosporine A nephrotoxicity.
Sun QL; Li M; Rui HL; Chen YP
J Renin Angiotensin Aldosterone Syst; 2015 Jun; 16(2):301-10. PubMed ID: 25500744
[TBL] [Abstract][Full Text] [Related]
5. Glucocorticoids activate cardiac mineralocorticoid receptors in adrenalectomized Dahl salt-sensitive rats.
Ohtake M; Hattori T; Murase T; Takahashi K; Takatsu M; Ohtake M; Miyachi M; Watanabe S; Cheng XW; Murohara T; Nagata K
Nagoya J Med Sci; 2014 Feb; 76(1-2):59-72. PubMed ID: 25129992
[TBL] [Abstract][Full Text] [Related]
6. Mineralocorticoid receptor blockade and calcium channel blockade have different renoprotective effects on glomerular and interstitial injury in rats.
Du J; Fan YY; Hitomi H; Kiyomoto H; Kimura S; Kong CZ; Noma T; Kohno M; Nishiyama A; Nakano D
Am J Physiol Renal Physiol; 2009 Sep; 297(3):F802-8. PubMed ID: 19535572
[TBL] [Abstract][Full Text] [Related]
7. Effect of eplerenone on hypertension-associated renal damage in rats: potential role of peroxisome proliferator activated receptor gamma (PPAR-γ).
Miana M; de Las Heras N; Rodriguez C; Sanz-Rosa D; Martin-Fernandez B; Mezzano S; Lahera V; Martinez-Gonzalez J; Cachofeiro V
J Physiol Pharmacol; 2011 Feb; 62(1):87-94. PubMed ID: 21451213
[TBL] [Abstract][Full Text] [Related]
8. Mineralocorticoid receptor--Rac1 activation and oxidative stress play major roles in salt-induced hypertension and kidney injury in prepubertal rats.
Kawarazaki H; Ando K; Shibata S; Muraoka K; Fujita M; Kawarasaki C; Fujita T
J Hypertens; 2012 Oct; 30(10):1977-85. PubMed ID: 22914542
[TBL] [Abstract][Full Text] [Related]
9. Preclinical pharmacology of AZD9977: A novel mineralocorticoid receptor modulator separating organ protection from effects on electrolyte excretion.
Bamberg K; Johansson U; Edman K; William-Olsson L; Myhre S; Gunnarsson A; Geschwindner S; Aagaard A; Björnson Granqvist A; Jaisser F; Huang Y; Granberg KL; Jansson-Löfmark R; Hartleib-Geschwindner J
PLoS One; 2018; 13(2):e0193380. PubMed ID: 29474466
[TBL] [Abstract][Full Text] [Related]
10. CS-3150, a novel non-steroidal mineralocorticoid receptor antagonist, prevents hypertension and cardiorenal injury in Dahl salt-sensitive hypertensive rats.
Arai K; Tsuruoka H; Homma T
Eur J Pharmacol; 2015 Dec; 769():266-73. PubMed ID: 26607463
[TBL] [Abstract][Full Text] [Related]
11. The effects of aldosterone on diet-induced fatty liver formation in male C57BL/6 mice: comparison of adrenalectomy and mineralocorticoid receptor blocker.
Gamliel-Lazarovich A; Raz-Pasteur A; Coleman R; Keidar S
Eur J Gastroenterol Hepatol; 2013 Sep; 25(9):1086-92. PubMed ID: 23524523
[TBL] [Abstract][Full Text] [Related]
12. Effects of brain mineralocorticoid receptor blockade on blood pressure and renal functions in DOCA-salt hypertension.
Rahmouni K; Sibug RM; De Kloet ER; Barthelmebs M; Grima M; Imbs JL; De Jong W
Eur J Pharmacol; 2002 Feb; 436(3):207-16. PubMed ID: 11858800
[TBL] [Abstract][Full Text] [Related]
13. Chronic antagonism of the mineralocorticoid receptor ameliorates hypertension and end organ damage in a rodent model of salt-sensitive hypertension.
Zhou X; Crook MF; Sharif-Rodriguez W; Zhu Y; Ruben Z; Pan Y; Urosevic-Price O; Wang L; Flattery AM; Forrest G; Szeto D; Zhao H; Roy S; Forrest MJ
Clin Exp Hypertens; 2011; 33(8):538-47. PubMed ID: 21950654
[TBL] [Abstract][Full Text] [Related]
14. Role of mineralocorticoid receptor/Rho/Rho-kinase pathway in obesity-related renal injury.
Tokuyama H; Wakino S; Hara Y; Washida N; Fujimura K; Hosoya K; Yoshioka K; Hasegawa K; Minakuchi H; Homma K; Hayashi K; Itoh H
Int J Obes (Lond); 2012 Aug; 36(8):1062-71. PubMed ID: 22184057
[TBL] [Abstract][Full Text] [Related]
15. Mineralocorticoid receptor antagonism attenuates cardiac hypertrophy and failure in low-aldosterone hypertensive rats.
Nagata K; Obata K; Xu J; Ichihara S; Noda A; Kimata H; Kato T; Izawa H; Murohara T; Yokota M
Hypertension; 2006 Apr; 47(4):656-64. PubMed ID: 16505208
[TBL] [Abstract][Full Text] [Related]
16. Activation of mineralocorticoid receptors in the rostral ventrolateral medulla is involved in hypertensive mechanisms in stroke-prone spontaneously hypertensive rats.
Nakagaki T; Hirooka Y; Matsukawa R; Nishihara M; Nakano M; Ito K; Hoka S; Sunagawa K
Hypertens Res; 2012 Apr; 35(4):470-6. PubMed ID: 22237482
[TBL] [Abstract][Full Text] [Related]
17. Mineralocorticoid receptor antagonist reduces renal injury in rodent models of types 1 and 2 diabetes mellitus.
Guo C; Martinez-Vasquez D; Mendez GP; Toniolo MF; Yao TM; Oestreicher EM; Kikuchi T; Lapointe N; Pojoga L; Williams GH; Ricchiuti V; Adler GK
Endocrinology; 2006 Nov; 147(11):5363-73. PubMed ID: 16901964
[TBL] [Abstract][Full Text] [Related]
18. Podocyte as the target for aldosterone: roles of oxidative stress and Sgk1.
Shibata S; Nagase M; Yoshida S; Kawachi H; Fujita T
Hypertension; 2007 Feb; 49(2):355-64. PubMed ID: 17200434
[TBL] [Abstract][Full Text] [Related]
19. Role of mineralocorticoid receptor on experimental cerebral aneurysms in rats.
Tada Y; Kitazato KT; Tamura T; Yagi K; Shimada K; Kinouchi T; Satomi J; Nagahiro S
Hypertension; 2009 Sep; 54(3):552-7. PubMed ID: 19620512
[TBL] [Abstract][Full Text] [Related]
20. Molecular mechanisms and therapeutic strategies of chronic renal injury: renoprotective effects of aldosterone blockade.
Nishiyama A; Abe Y
J Pharmacol Sci; 2006 Jan; 100(1):9-16. PubMed ID: 16397374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
